Statistical power considerations in genotype-based recall randomized controlled trials

Randomized controlled trials (RCT) are often underpowered for validating gene-treatment interactions. Using published data from the Diabetes Prevention Program (DPP), we examined power in conventional and genotype-based recall (GBR) trials. We calculated sample size and statistical power for gene-me...

Descripción completa

Detalles Bibliográficos
Autores principales: Atabaki-Pasdar, Naeimeh, Ohlsson, Mattias, Shungin, Dmitry, Kurbasic, Azra, Ingelsson, Erik, Pearson, Ewan R., Ali, Ashfaq, Franks, Paul W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122840/
https://www.ncbi.nlm.nih.gov/pubmed/27886175
http://dx.doi.org/10.1038/srep37307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122840/
https://www.ncbi.nlm.nih.gov/pubmed/27886175
http://dx.doi.org/10.1038/srep37307

Ejemplares similares